期刊文献+

IFN-γ基因转导A549细胞对异种小鼠S_(180)抑瘤作用 被引量:2

Inhibitive Effect of IFN-γ Gene Transduced A549 Cell on Xenogeneic S180-bearing Mice
下载PDF
导出
摘要 [目的]探讨γ鄄干扰素(IFN鄄γ)转基因疫苗对异种小鼠S180肿瘤的抑瘤作用及其影响因素。[方法]将IFN鄄γ基因修饰的转化细胞株,经γ鄄60Co照射后制成转基因疫苗,测定其MHC鄄Ⅰ、Ⅱ分子的表达,以及60Co照射与冻融等因素对其影响。在添加肿瘤细胞裂解物和GM鄄CSF、IL鄄2及变换注射部位等,观察对异种荷瘤S180小鼠的抑瘤作用。[结果]经IFN鄄γ基因修饰后,其细胞表达MHC鄄Ⅰ、Ⅱ分子明显提高,该两分子的上调并不受照射及冻融等因素的影响。变换注射部位及用IL鄄2取代转基因疫苗作预防性注射后依然有抑瘤作用。[结论]经IFN鄄γ基因修饰的A549细胞疫苗其MHC鄄Ⅰ、Ⅱ分子的上调并不受照射、冻融等因素及变换注射部位的影响,仍可对异种动物肿瘤产生较强的免疫抑瘤作用。 Purpose] To investigate the inhibitive effect and related factors of the γ-interferon(IFN-γ) transgenic vaccine on xenogeneic S180-bearing mice. [Methods] IFN-γ gene transduced vaccine was obtained from IFN-γ transformation cell line after 60Co radiation. MHC-Ⅰ?Ⅱ molecule expressing levels were detected and their changes were evaluated by means of the radiation and freezing. Inhibition effect on the xenogeneic S180-bearing mice was evaluated after changing the injection site and adding GM-CSF, IL-2 and tumor cell lysates. [Results] The cell line could express high MHC-Ⅰ?Ⅱ levels after being transduced by IFN-γ gene which were not affected under 60Co radiation and freezing condition. The inhibition affects were not effected after changing the injection site and using IL-2 as a replacing transgenic vaccine. [Conclusion] The results suggest that the IFN-γ transgenic A549 cell vaccine under different condition such as: radiation and freezing, or change injecting site, or using IL-2 to preplace the transgenic vaccine could still have a strong inhibitive effect on the xenogeneic mouse tumor.
机构地区 浙江大学医学院
出处 《肿瘤学杂志》 CAS 2005年第3期182-184,共3页 Journal of Chinese Oncology
关键词 干扰素Ⅱ型 肺肿瘤 肿瘤细胞 培养的 鼠科 interferon type Ⅱ lung neoplasms tumor cells, cultured muridae
  • 相关文献

参考文献6

  • 1Saito R, Mizuno M, Nakahara N, et al. Vaccination with tumor cell lysate-pulsed dendritic cell augments the effect of IFN-γ gene therapy for malignant glioma in an experimental mouse intracranial glioma[J]. Int J Cancer, 2004,111(5):777-782.
  • 2于晓虹,刘祥麟,马洁羽.γ-干扰素基因修饰A549细胞瘤苗研究[J].细胞生物学杂志,2002,24(6):379-382. 被引量:1
  • 3Dyall R, Bowne WB, Weber LW, et al. Heteroclitic immunization induces tumor immunity[J]. J Exp Med, 1998,188(9):1553-1561.
  • 4Sang H, Pisarev VM, Chavez J, et al. Murine mammary adenocarcinoma cells transfected with p53 and/or Flt3L induce antitumor immune responses [J]. Cancer Gene Ther, 2005,12(4):427-437.
  • 5Stagg J, Wu JH, Bouganim N, et al. Granulocytemacrophage colony-stimulating factor and interleukin-2fusion cDNA for cancer gene immunotherapy[J]. Cancer Res, 2004, 64(24):8795-8799.
  • 6Shimizu K, Fields RC, Giedlin M, et al. Sytemic administration of interleukin 2 enhance the therapentic efficacy of dendritic cell-base tumor vaccine [J]. Proc Nat] Acad Sci USA, 1999:2268-2273.

二级参考文献1

同被引文献57

  • 1庄东刚,吴逸明,巴月.肺癌患者MAGE-A3抗原表达及HLA-I类基因分布的初步研究[J].河南预防医学杂志,2004,15(4):193-196. 被引量:1
  • 2邓波,林一丹,王如文,蒋耀光.利用PCR-SSP法研究肺腺癌细胞系A549、Calu-6的HLA-ABDR等位基因[J].中国肺癌杂志,2006,9(2):113-116. 被引量:2
  • 3Baba T, Hanagiri T, Ichiki Y, et al. Lack and restoration of sensitivity of lung cancer cells to cellular attack with special reference to expression of human leukocyte antigen class I and/or major histocompatibility complex class I chain related molecules A/B. Cancer Sci, 2007, 98(11): 1795-1802.
  • 4Kikuchi E, Yamazaki K, Torigoe T, et al. HLA class I antigen expression is associated with a favorable prognosis in early stage non-small cell lung cancer. Cancer Sci, 2007, 98(9): 1424-1430.
  • 5Suzuki H, Higuchi M, Hasegawa T, et al. Tissue array analysis of the aberrant expression of HLA class I molecules in human non small cell lung cancer. Gan To Kagaku Ryoho, 2006, 33(12): 1713-1716.
  • 6Ramnath N, Tan D, Li Q, et al. Is downregulation of MHC class I antigen expression in human non-small cell lung cancer associated with prolonged survival? Cancer Immunol Immunother, 2006, 55(8): 891-899.
  • 7Nagata Y, Hanagiri Tj Mizukami M, et al. Clinical significance of HLA class I alleles on postoperative prognosis of lung cancer patients in Japan. Lung Cancer, 2009, 65(1): 91-97.
  • 8Yie SM, Yang H, Ye SR, et al. Expression of human leucocyte antigen G (HLA-G) is associated with prognosis in non-small cell lung cancer. Lung Cancer, 2007, 58(2): 267-274.
  • 9Paschen A, Arens N, Sucker A, et al. The coincidence of chromosome 15 aberrations and beta2-microglobulin gene mutations is causative for the total loss of human leukocyte antigen class I expression in melanoma. Clin Cancer Res, 2006, 12(11): 3297-3305.
  • 10Corrias MV, Occhino M, Croce M, et al. Lack of HLA-class I antigens in human neuroblastoma cells: analysis of its relationship to TAP and tapasin expression. Tissue Antigens, 2001, 57(2): 110-117.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部